Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells. | Nat Biomed Eng | 2022 | 35941192 | PubTator, text mining | PubMed |
| Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer. | Front Mol Biosci | 2022 | 35936781 | PubTator, text mining | PubMed |
A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. | Front Immunol | 2022 | 35935989 | PubTator, text mining | PubMed |
| The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes. | Front Immunol | 2022 | 35935980 | PubTator, text mining | PubMed |
| A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma. | Front Immunol | 2022 | 35935979 | PubTator, text mining | PubMed |
| Role of Vγ9vδ2 T lymphocytes in infectious diseases. | Front Immunol | 2022 | 35924233 | PubTator, text mining | PubMed |
| Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy. | Immunother Adv | 2022 | 35919494 | PubTator, text mining | PubMed |
| Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma. | Transl Oncol | 2022 | 35917642 | PubTator, text mining | PubMed |
| CD137L and CD4 T cells limit BCL6-expressing pre-germinal center B cell expansion and BCL6-driven B cell malignancy. | Immunol Cell Biol | 2022 | 35916066 | PubTator, text mining | PubMed |
| THEM6: A Novel Molecular Biomarker Predicts Tumor Microenvironment, Molecular Subtype, and Prognosis in Bladder Cancer. | Dis Markers | 2022 | 35909893 | PubTator, text mining | PubMed |
| CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies. | Clin Transl Med | 2022 | 35908284 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Aberrance and Functional Significance of Ferroptosis in Gastric Cancer. | Front Pharmacol | 2022 | 35903347 | PubTator, text mining | PubMed |
| Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors. | Front Immunol | 2022 | 35903099 | PubTator, text mining | PubMed |
| Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments. | Elife | 2022 | 35894206 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development. | Vaccines (Basel) | 2022 | 35893817 | PubTator, text mining | PubMed |
| Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms. | Cancers (Basel) | 2022 | 35884612 | PubTator, text mining | PubMed |
| γδ T Cell-Based Adoptive Cell Therapies Against Solid Epithelial Tumors. | Cancer J | 2022 | 35880936 | PubTator, text mining | PubMed |
| γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells. | Front Immunol | 2022 | 35880177 | PubTator, text mining | PubMed |
| Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination. | Front Immunol | 2022 | 35874675 | PubTator, text mining | PubMed |
| HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in Glioma. | J Oncol | 2022 | 35865089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=43